Chondroitin: benefits, dosage, contraindications
Other name(s)
Chondroitin polysulfate
Scientific name(s)
Chondroitin 4-sulfate
Family or group:
Carbohydrates
Active ingredients:
Glucuronic acid
Galactosamine
Indications
Rating methodology
EFSA approval.
Osteoarthritis ✪✪✪✪✪
Clinical research shows that taking chondroitin sulfate improves symptoms of osteoarthritis. Several clinical trials have shown that daily oral intake of 800 mg to 2000 mg in single or divided doses for at least 3 months reduces pain and may improve mobility in patients suffering from osteoarthritis. Clinical trials conducted over 2 years show that oral intake of chondroitin sulfate at a dose of 800 mg slows the progression of hip or knee osteoarthritis.
Posologie
Synergies
Comparative Efficacy and Safety Study of Two Chondroitin Sulfate Preparations From Different Origin (Avian and Bovine) in Symptomatic Osteoarthritis of the Knee
Glucosamine, Chondroitin Sulfate, and the Two in Combination for Painful Knee Osteoarthritis
Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis.
Comparison of the Antiinflammatory Efficacy of Chondroitin Sulfate and Diclofenac Sodium in Patients With Knee Osteoarthritis
Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI
Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens
In a two-year double-blind randomized controlled multicenter study, chondroitin sulfate was significantly superior to celecoxib at reducing cartilage loss with similar efficacy at reducing disease symptoms in knee osteoarthritis patients
Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration
Effects of chondroitin sulfate in the pathophysiology of the osteoarthritic joint: a narrative review
Dry eye syndrome ✪✪✪✪✪
In a double-blind study, the application of 1% chondroitin sulfate was found to be as effective as the formulation of polyvinyl alcohol artificial tears and 0.1% hyaluronic acid in reducing itching, burning, and foreign body sensation in individuals with dry eye keratoconjunctivitis.
Posologie
Topical application of hyaluronic acid and chondroitin sulfate in the treatment of dry eyes
The Effects of Sodium Hyaluronate, Chondroitin Sulfate, and Methylcellulose on the Corneal Endothelium and Intraocular Pressure
Psoriasis ✪✪✪✪✪
It has been found that some patients with psoriasis show significant clinical and histological improvement of psoriatic lesions after taking chondroitin for their osteoarthritis. This effect was confirmed in a clinical trial suggesting that chondroitin may be particularly beneficial in patients with both conditions, especially since anti-inflammatory treatment can induce or exacerbate psoriasis.
Posologie
Clinical and histopathological improvement of psoriasis in patients with osteoarthritis treated with chondroitin sulfate: report of 3 cases
Effectiveness of chondroitin sulphate in patients with concomitant knee osteoarthritis and psoriasis: a randomized, double-blind, placebo-controlled study
Properties
Vision
Chondroitin has viscoelastic properties that make it useful for ophthalmic applications. Chondroitin sulfate is used as a viscoelastic substance to protect and lubricate cells and tissues during eye surgery, as well as to preserve corneas prior to transplantation. In in vitro corneal organ cultures, chondroitin sulfate inhibited the adhesion of Candida albicans.
Usages associés
Bone Density
Chondroitin has anti-arthritic effects through the stimulation of proteoglycan synthesis (it is a glycoprotein, a combination of a protein and a glycosaminoglycan) and the reduction of the catabolic activity of chondrocytes (the cells composing cartilage). It inhibits the synthesis of proteolytic enzymes and has anti-inflammatory activity and actions on osteoblasts in subchondral bone, with a reduction in bone resorption. Furthermore, chondroitin seems to protect cartilage from degradation by inhibiting synovial fluid enzymes, such as elastase and hyaluronidase, which damage articular cartilage. It improves the nutrition of chondrocytes by increasing the production of hyaluronic acid in joint cells and thus the fluid content of the extracellular matrix, which not only acts as a shock absorber but also brings nutrients into the cartilage.
Usages associés
Anti-inflammatory
Chondroitin has an anti-inflammatory action with an inhibitory effect on complement. In an in vitro study of bovine cartilage, chondroitin alone, and in combination with glucosamine, regulates gene expression and the synthesis of nitric oxide and prostaglandin E2, which may explain its anti-inflammatory properties. It has been suggested that the multiple anti-inflammatory effects of chondroitin in chondrocytes and synoviocytes are primarily due to a common mechanism, through the inhibition of nuclear translocation of NF-κB (a protein involved in immune response and cellular stress response). Additionally, it has also been demonstrated that chondroitin sulfate inhibits the production of prostaglandin E2 and matrix metalloproteinases (a family of enzymes of the peptidase class, containing a metallic ion in their active site) in osteoblasts, suggesting that the action of chondroitin in osteoarthritis is not solely due to effects on cartilage, but may also be due to effects on subchondral bone.
Usages associés
Anticancer
In vitro evidence suggests that exogenous chondroitin sulfate regulates the adhesion, motility, and migration of fibrosarcoma cells (a malignant tumor originating in fibrous connective tissues). There is also evidence that chondroitin could be useful in cancer monitoring. Indeed, the concentration of chondroitin sulfate is increased in the prostate tissue of men with prostate cancer. There is evidence that measures of endogenous chondroitin sulfate in the peritumoral stromal tissue of the prostate may be a useful biomarker in the progression of prostate cancer disease.
Antiviral
Preliminary research suggests that the oversulfated chemical form of chondroitin has activity against HIV, herpes simplex virus, human cytomegalovirus, and dengue virus.
Neurological
In vitro and in vivo evidence suggests that the antioxidant and anti-inflammatory effects of chondroitin contribute to its neuroprotective properties.
Safety dosage
Adults: 800 mg - 2000 mg
Orally, chondroitin sulfate has been used safely at doses of up to 2000 mg per day for 6 years. Topical creams intended for skin use can also be used safely.
Interactions
Médicaments
Warfarin: moderate interaction
Taking chondroitin in combination with glucosamine may increase the anticoagulant effects of warfarin (Coumadin) and increase the risk of bruising and bleeding.
Precautions
Pregnant women: avoid
Reliable information is insufficient to provide advice on safety during pregnancy.
Breastfeeding women: avoid
Avoid use due to a lack of reliable and sufficient information.
Asthma: use with caution
There is a concern that chondroitin may exacerbate asthma. Asthmatic patients tend to have higher levels of anti-chondroitin antibodies in their airways compared to non-asthmatics.